Na+/K+ carrier ionophore antibiotics valinomycin and monensin enhance the antibacterial activity of fluoride
- PMID: 37069308
- DOI: 10.1038/s41429-023-00619-w
Na+/K+ carrier ionophore antibiotics valinomycin and monensin enhance the antibacterial activity of fluoride
Abstract
Fluoride is routinely used as a highly effective antibacterial agent that interferes with bacterial metabolism through fundamentally different mechanisms. One of the major bacterial evasion mechanisms against fluoride is the impermeability of cell envelope to the anion that limits its cellular uptake. Therefore, translating such compounds to clinical settings requires novel mechanisms to facilitate the uptake of membrane-impermeant molecules. Published data have indicated antibiotic synergy between fluoride and membrane destabilizing agents that induce strong fluoride toxicity in bacteria via enhancing the permeability of bacterial membranes to fluoride. Here, we report a similar mechanism of antibiotic synergy between fluoride and potassium ion carriers, valinomycin and monensin against Gram-positive bacteria, B. subtilis and S. aureus. Molecular dynamics simulations were performed to understand the effect of potassium on the binding affinity of fluoride to monensin and valinomycin. The trajectory results strongly indicated that the monensin molecules transport fluoride ions across the cell membrane via formation of ion-pair between the monensin-K+ complex and a fluoride. This study provides new insights to design novel compounds to enhance the uptake of small toxic anions via synergistic interactions and thus exert strong antibacterial activity against a wide variety of pathogens.
© 2023. The Author(s), under exclusive licence to the Japan Antibiotics Research Association.
References
-
- Jackson N, Czaplewski L, Piddock LJV. Discovery and Development of New Antibacterial Drugs: Learning from Experience? J Antimicrob Chemother. 2018;73:1452–9. https://doi.org/10.1093/jac/dky019 . - DOI - PubMed
-
- Read AF, Woods RJ. Antibiotic Resistance Management. Evol Med Public Heal. 2014;2014:147. https://doi.org/10.1093/emph/eou024 . - DOI
-
- Fair RJ, Tor Y. Antibiotics and Bacterial Resistance in the 21st Century. Perspect Med Chem. 2014;6:25–64. https://doi.org/10.4137/PMC.S14459 . - DOI
-
- Doern CD. When Does 2 plus 2 Equal 5? A Review of Antimicrobial Synergy Testing. J Clin Microbiol. 2014;52:4124–8. https://doi.org/10.1128/JCM.01121-14 . - DOI - PubMed - PMC
-
- Xu X, Xu L, Yuan G, Wang Y, Qu Y, Zhou M. Synergistic Combination of Two Antimicrobial Agents Closing Each Other’s Mutant Selection Windows to Prevent Antimicrobial Resistance. Sci Rep. 2018;8:1–7. https://doi.org/10.1038/s41598-018-25714-z . - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
